Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study in Patients Undergoing AnthRacycline-Based Chemotherapy to Assess the Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

NCT01032278 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01032278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01032278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study in Patients Undergoing AnthRacycline-Based Chemotherapy to Assess the Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 25, 2011
Completion date
January 31, 2021
Enrollment
597 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac toxicity, unspecified adult solid tumor, protocol specific